Zhibo Pharmaceuticals-B (02591) has recently filed its latest shareholder equity disclosure, dated August 21, 2026.

According to the filing, shareholder Huang Li has adjusted her long position in the company. Her holdings decreased from 38.6111 million shares to 37.4911 million shares.

Following this change, the latest shareholding percentage stands at 8.92%, compared to the previous figure of 9.19%.

It is important to note that fluctuations in share counts may arise from corporate actions such as rights issues, share consolidations, or stock splits. Investors are advised to verify the details against the actual corporate circumstances.